A previously unreported variant in the UBE3A gene caused an inherited form of Angelman syndrome in six members of…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Early intervention with environmental stimulation appears to have restored motor coordination and behaviors in a mouse model of Angelman syndrome.
Computer analysis of the faces of Angelman syndrome patients found distinct facial features that changed from childhood to adulthood,…
A novel dual gene therapy rescued the function of the UBE3A gene in a mouse model of Angelman syndrome,…
Epilepsy starting at an earlier age and sleep problems independently predicted increased hyperactivity in Norwegian people with Angelman syndrome,…
OV101 (gaboxadol), designed to improve motor skills, cognition, and memory in people with…
Parents of children with Angelman syndrome think gene therapy trials to find a cure…